Trial Outcomes & Findings for Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart (NCT NCT02709395)
NCT ID: NCT02709395
Last Updated: 2023-01-26
Results Overview
PRO Questionnaire, completed by each subject after 4 weeks of using Navina Smart, collecting data on subject's assessment of satisfaction when using the study device. Satisfaction was assessed in a range of ways through different questions to be answered by each subject. For example each subject received the question "If possible, would you consider continuing using the Navina Smart system?"
COMPLETED
NA
28 participants
4 weeks
2023-01-26
Participant Flow
Participant milestones
| Measure |
Navina Smart
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Overall Study
STARTED
|
28
|
|
Overall Study
COMPLETED
|
19
|
|
Overall Study
NOT COMPLETED
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Data missing for 4 subjects, no response received
Baseline characteristics by cohort
| Measure |
Navina Smart
n=28 Participants
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Age, Continuous
|
53.17 years
n=28 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=28 Participants
|
|
Sex: Female, Male
Male
|
17 Participants
n=28 Participants
|
|
Bowel Management at Baseline - Satisfaction
Not Satisfied - Not satisfied at all
|
11 Participants
n=28 Participants
|
|
Bowel Management at Baseline - Satisfaction
Neutral
|
7 Participants
n=28 Participants
|
|
Bowel Management at Baseline - Satisfaction
Satisfied - Completely satisfied
|
10 Participants
n=28 Participants
|
|
TAI therapy at Baseline
Peristeen
|
28 Participants
n=28 Participants
|
|
TAI therapy at Baseline
Other
|
0 Participants
n=28 Participants
|
|
Time spent bowel management at Baseline
|
54.90 minutes
n=24 Participants • Data missing for 4 subjects, no response received
|
PRIMARY outcome
Timeframe: 4 weeksPopulation: Intention To Treat Analysis Set
PRO Questionnaire, completed by each subject after 4 weeks of using Navina Smart, collecting data on subject's assessment of satisfaction when using the study device. Satisfaction was assessed in a range of ways through different questions to be answered by each subject. For example each subject received the question "If possible, would you consider continuing using the Navina Smart system?"
Outcome measures
| Measure |
Navina Smart
n=28 Participants
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Questionnaire Measuring Subjects' Satisfaction of Navina Smart
Answer missing
|
1 Participants
|
|
Questionnaire Measuring Subjects' Satisfaction of Navina Smart
Yes
|
14 Participants
|
|
Questionnaire Measuring Subjects' Satisfaction of Navina Smart
No
|
13 Participants
|
PRIMARY outcome
Timeframe: 4 weeksPopulation: Intention To Treat Analysis Set
PRO Questionnaire, completed by each subject after 4 weeks of using Navina Smart, collecting data on subject's assessment of perception when using the study device. For example, each subject answered the following question regarding perception: "How satisfied are you with the Navina Smart System?"
Outcome measures
| Measure |
Navina Smart
n=28 Participants
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Questionnaire Measuring Subjects' Perception of Navina Smart
Answer missing
|
1 Participants
|
|
Questionnaire Measuring Subjects' Perception of Navina Smart
Neutral, satisfied or very satisfied with Navina
|
18 Participants
|
|
Questionnaire Measuring Subjects' Perception of Navina Smart
Not satisfied with Navina
|
9 Participants
|
PRIMARY outcome
Timeframe: 4 weeksPopulation: Intention To Treat Analysis Set
PRO Questionnaire, completed by each subject after 4 weeks of using Navina Smart, collecting data on subject's compliance towards the study device. For example, each subject answered the following question "Did you use the Navina Smart system for 4 weeks?"
Outcome measures
| Measure |
Navina Smart
n=28 Participants
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Questionnaire Measuring Subjects' Compliance of Navina Smart
Answer missing
|
0 Participants
|
|
Questionnaire Measuring Subjects' Compliance of Navina Smart
Yes
|
19 Participants
|
|
Questionnaire Measuring Subjects' Compliance of Navina Smart
No
|
9 Participants
|
SECONDARY outcome
Timeframe: 4 weeksPopulation: Safety Analysis Set
Total numbers and types of AEs, ADEs and SAEs observed by the study staff or spontaneously reported from the patient.
Outcome measures
| Measure |
Navina Smart
n=28 Participants
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Adverse Events (AEs), Adverse Device Effects (ADEs), Serious Adverse Events (SAEs) Related to Navina Smart
|
3 number of events
|
Adverse Events
Navina Smart
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Navina Smart
n=28 participants at risk
Navina Smart will be used, during 4 weeks, for transanal irrigation (TAI).
Navina Smart: Transanal irrigation at the same frequency as subject used before enrollment.
|
|---|---|
|
Injury, poisoning and procedural complications
Broke left leg
|
3.6%
1/28 • The safety of Navina Smart, e.g. registration of Adverse Events (AEs), Adverse Device Effects (ADEs), Serious Adverse Events (SAEs), were collected throughout the study period for 4 weeks of each participating subject.
|
|
Gastrointestinal disorders
Vomiting
|
3.6%
1/28 • The safety of Navina Smart, e.g. registration of Adverse Events (AEs), Adverse Device Effects (ADEs), Serious Adverse Events (SAEs), were collected throughout the study period for 4 weeks of each participating subject.
|
|
Skin and subcutaneous tissue disorders
Skin infection elbow
|
3.6%
1/28 • The safety of Navina Smart, e.g. registration of Adverse Events (AEs), Adverse Device Effects (ADEs), Serious Adverse Events (SAEs), were collected throughout the study period for 4 weeks of each participating subject.
|
Additional Information
Head of Medical Affairs, Markus Wittebo
Wellspect HealthCare
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place